Glipizide

Dr. McPhee: This is not quite right for Mr. Green. Glipizide is a sulfonylurea that stimulates insulin secretion from the pancreas and thus can be used in type 2 diabetes in cases where first line drugs are not indicated or unavailable. However, it increases the risk of hypoglycaemia and tends to cause weight gain, which are not ideal for a patient who is overweight and has a history of hypertension. Sulfonylureas do not provide the same cardiovascular protection as other drugs, which is a major goal of diabetes management. Think carefully about the broader health context for Mr. Green and try again!

  • Option 1 [undo]
  • Provide tele-wound care education [undo]
  • Presentation [undo]
  • Ανεπιθύμητες ενέργειες φαρμακευτικής αγωγής [undo]
  • 10/10000 [undo]
  • White [undo]
  • Descrierea 3 [undo]
  • Node 9: Reassure her receive continuous supportw node [undo]
  • Grapefruit-simvastatin interaction [undo]
  • Inhibits the conversion of fibrinogen to fibrin [undo]
  • Buy non prescribed anti-anxiety medication [undo]
  • Ionuț va cere bani de la mama sa. [undo]
  • (1) προφάση, (2) μεσοφάση, (3) τελόφαση, (4) προμεταφάση, (5) μετάφαση και (6) ανάφαση [undo]
  • Node 10: Move to scheduling follow-up sessions [undo]
  • Live specimens [undo]
  • Node 14: Provide a support contact for technical issues [undo]
  • The result [undo]
  • Respond bluntly: “That is common in diabetes.” [undo]
  • The onset [undo]
  • Που θα οδηγήσει [undo]
  • Descrierea 2 [undo]
  • Commercial Platform [undo]
  • Ignore the emotional expression. [undo]
  • Temporarily stop taking metformin [undo]
  • Η εκπαιδευτικός μοιράζει τους ρόλους των ηθοποιών [undo]
  • Connecting Care Virtually: Building Trust and Teamwork in Digital Health Communication [undo]
  • Increased entry of fatty acids into adipocytes [undo]
  • Genotyping mice for the noveltin gene I: PCR Reagents [undo]
  • Decreased entry of glucose into muscle cells [undo]
  • 8 y.o. Child came in the ER with his mother [undo]
  • What should Anna do? [undo]
  • 27 [undo]
  • Verify patient identity and obtain e-consent before starting. [undo]
  • Option 2 [undo]
  • Gastrointestinal symptoms [undo]
  • Glipizide [undo]

Map: Michael Green_GEMD_2 (1116)
Node: 21113
Score:

reset

OpenLabyrinth
OpenLabyrinth is an open source educational pathway system

Review your pathway